Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2
Express Pharma
JUNE 20, 2025
Rising expectations for scientific rationale One consistent theme across FDA communications, including 483s, Warning Letters, and guidance documents is the demand for sound scientific justification behind design and operational decisions. PDA TR 22, ISO 14644, ICH Q9, Q10) adequately supported by the relevant data set.
Let's personalize your content